Log in

Innovation Pharmaceuticals Stock Price, Forecast & Analysis (OTCMKTS:IPIX)

0.00 (-6.02 %)
(As of 11/16/2019 08:00 AM ET)
Today's Range
Now: $0.08
50-Day Range
MA: $0.10
52-Week Range
Now: $0.08
Volume551,747 shs
Average Volume444,035 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug compound is Brilacidin, which is in Phase II study for the treatment of oral mucositis, inflammatory bowel disease, and acute bacterial skin and skin structure infection. It also develops Prurisol, a Phase IIb compound, which is in development for psoriasis; and Kevetrin, a lead anti-cancer compound for treating ovarian cancer. In addition, the company owns other candidates for treating diseases, including autism, arthritis, asthma, MS/ALS/Parkinson's, cancer, hypertensive emergency, and bacterial and fungal infections. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Beverly, Massachusetts.

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolOTCMKTS:IPIX
Phone(978) 236-8717



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive IPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for IPIX and its competitors with MarketBeat's FREE daily newsletter.

Innovation Pharmaceuticals (OTCMKTS:IPIX) Frequently Asked Questions

What is Innovation Pharmaceuticals' stock symbol?

Innovation Pharmaceuticals trades on the OTCMKTS under the ticker symbol "IPIX."

Has Innovation Pharmaceuticals been receiving favorable news coverage?

Headlines about IPIX stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Innovation Pharmaceuticals earned a daily sentiment score of 2.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Innovation Pharmaceuticals.

Who are some of Innovation Pharmaceuticals' key competitors?

What other stocks do shareholders of Innovation Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innovation Pharmaceuticals investors own include Cronos Group (CRON), Ideal Power (IPWR), Aphria (APHA), 22nd Century Group (XXII), Andrea Electronics (ANDR), Cannabix Technologies (BLOZF), CV Sciences (CVSI), Emerald Health Therapeutics (EMHTF), Achillion Pharmaceuticals (ACHN) and Activision Blizzard (ATVI).

Who are Innovation Pharmaceuticals' key executives?

Innovation Pharmaceuticals' management team includes the folowing people:
  • Mr. Leo Ehrlich, Chairman, CEO, CFO, Principal Accounting Officer & Sec. (Age 61)
  • Dr. Arthur Peter Bertolino, Pres, Chief Medical Officer & Director (Age 64)
  • Ms. Jane Harness, Sr. VP of Clinical Sciences & Portfolio Management (Age 51)
  • Dr. W. James Alexander M.D., MPH, FACP, Consultant (Age 69)
  • Dr. Paul Ginsburg, Scientific Advisor & Member of Advisory Board

How do I buy shares of Innovation Pharmaceuticals?

Shares of IPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innovation Pharmaceuticals' stock price today?

One share of IPIX stock can currently be purchased for approximately $0.08.

What is Innovation Pharmaceuticals' official website?

The official website for Innovation Pharmaceuticals is http://www.cellceutix.com/.

How can I contact Innovation Pharmaceuticals?

Innovation Pharmaceuticals' mailing address is 100 Cummings Ctr Ste 151b, BEVERLY, MA 01915-6117, United States. The company can be reached via phone at (978) 236-8717.

MarketBeat Community Rating for Innovation Pharmaceuticals (OTCMKTS IPIX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Innovation Pharmaceuticals and other stocks. Vote "Outperform" if you believe IPIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel